NCT01042587

Brief Summary

The investigators hypothesize that significant exposure to artificial morning bright light (approximately 200 lux of primarily blue light at eye level for thirty minutes daily) as compared to sham bright red light (placebo) will:

  1. 1.improve sleep quality
  2. 2.improve cognitive scores
  3. 3.improve depression scores
  4. 4.improve quality of life scores.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 4, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 5, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

August 11, 2010

Status Verified

March 1, 2010

Enrollment Period

3 months

First QC Date

January 4, 2010

Last Update Submit

August 10, 2010

Conditions

Keywords

bright light therapycircadian rhythm,entrainment

Outcome Measures

Primary Outcomes (7)

  • assessment of cognitive functioning using MicroCog

    once prior to intervention, once near the end of intervention, once four weeks after intervention

  • Assessment of mood using the Geriatric Depression Scale

    once prior to intervention, once near the end of intervention, once four weeks after intervention

  • assessment of quality of life using the SF-36

    once prior to intervention, once near the end of intervention, once four weeks after intervention

  • assessment of sleep quality using the Pittsburgh Sleep Quality Index

    once prior to intervention, once near the end of intervention, once four weeks after intervention

  • assessment of mood using the Profile of Moods Survey

    weekly throughout the duration of the study

  • assessment of sleep quality using the Epworth Sleepiness Scale

    weekly throughout the duration of the study

  • day and nightime activity level (5 subjects per group only) using Actigraphy

    two weeks prior to light exposure and the second two weeks during light exposure (continuous measurements)

Secondary Outcomes (2)

  • salivary melatonin levels

    once prior and near the end of light exposure period

  • salivary cortisol levels

    once prior and near the end of light exposure period

Study Arms (2)

bright light

ACTIVE COMPARATOR

Bright light has been shown to entrain circadian rhythm so our treatment arm will use thirty minutes of early morning exposure to bright blue light for a four week period.

Other: exposure to bright light

red light

SHAM COMPARATOR

Low level red light is a weak entrainment stimulus of circadian rhythm. Elders in the control group will be exposed to low level red light as a placebo for thirty minutes daily for four weeks.

Other: low luminosity red light

Interventions

Elders will be engaged in an activity period which will focus their attention in the direction of bright light, thus ensuring viewing the light source for a daily exposure of thirty minutes.

Also known as: modified commercially available Phillips Color Graze.
bright light

Low level red light should not entrain circadian rhythm and will serve as a placebo control

Also known as: modified commercially available Phillips Color Graze
red light

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • residents in Masonic Villages, Elizabethtown, PA long term care
  • ability to give informed consent and complete the neuropsychological tests

You may not qualify if:

  • blindness
  • severe illness expected to preclude the ability to complete treatment
  • moderate to severe dementia that precludes the ability to complete testing
  • light sensitivity making treatment to light therapy uncomfortable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Masonic Villages

Elizabethtown, Pennsylvania, 17022, United States

Location

Study Officials

  • Noel H Ballentine, MD

    Milton S. Hershey Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 4, 2010

First Posted

January 5, 2010

Study Start

March 1, 2010

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

August 11, 2010

Record last verified: 2010-03

Locations